June 11, 2018
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.



The pre-registration deadline for the NRG Oncology Semiannual Meeting is June 22nd! Read more.

 

NRG Oncology Semiannual Meeting

Hurry – Only 11 more days to Pre-Register!
We hope you can join us for the NRG Oncology Semiannual Meeting, July 12-14, 2018 at the Philadelphia Marriott Downtown in Philadelphia, PA. The Pre-Registration deadline is June 22, 2018. The hotel registration deadline is June 20, 2018. We kindly ask that everyone please pre-register online for this meeting before the deadline! Registering onsite at the meeting will incur an additional $50 fee. Registration and meeting information is available on the NRG Oncology website.

Meeting Highlights

  • Summer Symposium: Thursday, July 12 -  8am-3pm ( Read more)
  • Digital Health and Personal Connected Health Minisymposium Thursday, July 12 - 1-3pm  ( Read more)
  • Health Disparities Workshop Special Session: Intervening on the Financial Toxicity of Cancer Care - Friday, July 13 – 7-9am ( Read more )
  • Scientific Session: Friday, July 13 -  8-10am ( Read more )
  • Social Media Workshop: Friday, July 13 - 10-11:30am *New Session!  (Read more)
  • Workshops! Plan to Attend!  NRG-BR005 and NRG-BR003/NSABP B-55/NRG-BR004 (details posted to the NRG Oncology  meeting page)

 


PENDING PROTOCOL RE-ACTIVATIONS
GYNECOLOGIC
NRG-GY007: Scheduled Activation Date: June 18, 2018; Version date: April 6, 2018 (will be posted on NRG Oncology).

NRG-GY009: Scheduled Activation Date: June 18, 2018; Version date: March 19, 2018 (will be posted on CTSU).

OTHER PROTOCOL NOTICES
1. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial.
Enrollment credited to NRG Oncology will count towards membership requirements.

2. GENITOURINARY
NRG-GU006: Health Canada has approved this study for sites in Canada. The NOL, site activation memo, and Health Canada documents are located on CTSU on the supplemental documents and site registration tabs.

3. HEAD & NECK
NRG-HN004: Lead-In Weekly Accrual Summary is available under the Patient Enrollment tab on CTSU.

4. VTOC Training
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for August 15, 2018.


DRUG SAFETY UPDATES AND INVESTIGATOR’S BROCHURE (IB) NOTICE
Safety updates and an IB notice have been issued for the following studies:  

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

INVESTIGATOR'S BROCHURE (IB)*

Durvalumab

NRG-HN004

CTSU

 

Entinostat

NRG-GY011

CTSU

X(CTSU)

Ipilimumab

NRG-BN002
NRG-GY003

NRG
NRG

 

Nivolumab

 

NRG-GY002
NRG-GY003

NRG
NRG

 

Olaparib

NRG-GY004
NRG-GY005

CTSU
CTSU

 

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://ctepcore.nci.nih.gov/OAOP/.  Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
American Association of Medical Dosimetrists (AAMD); Jun 17-21, 2018; Austin, TX
Multinational Association of Supportive Care in Cancer (MASCC); Jun 28-30, 2018; Vienna, Austria
Society for Neuro-Oncology (SNO); Nov 15-18, 2018; New Orleans, LA

Upcoming Abstract Submission Deadlines
American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Antonio, TX; Late-breaking Aug 1, 2018
European Society for Medical Oncology (ESMO); Oct 19-23, 2018;Munich, Germany; Late-breaking Sep 17, 2018
San Antonio Breast Cancer Symposium (SABCS); Dec 4-8, 2018; San Antonio, TX; due to publications committee Jun 19, 2018; meeting abstracts submission deadline Jul 3, 2018 (10 am CDT)

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse